ID   PASK_HUMAN              Reviewed;        1323 AA.
AC   Q96RG2; Q68DY3; Q6GSJ5; Q86XH6; Q99763; Q9UFR7;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   02-NOV-2010, entry version 104.
DE   RecName: Full=PAS domain-containing serine/threonine-protein kinase;
DE            Short=PAS-kinase;
DE            Short=PASKIN;
DE            Short=hPASK;
DE            EC=2.7.11.1;
GN   Name=PASK; Synonyms=KIAA0135;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PHOSPHORYLATION AT THR-1161
RP   AND THR-1165, MUTAGENESIS OF LYS-1028; THR-1161 AND THR-1165, AND
RP   VARIANT CYS-1266.
RC   TISSUE=Cervix carcinoma;
RX   MEDLINE=21374377; PubMed=11459942; DOI=10.1073/pnas.161284798;
RA   Rutter J., Michnoff C.H., Harper S.M., Gardner K.H., McKnight S.L.;
RT   "PAS kinase: an evolutionarily conserved PAS domain-regulated
RT   serine/threonine kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8991-8996(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS
RP   MET-694 AND CYS-1266.
RC   TISSUE=Bone marrow;
RX   MEDLINE=96127530; PubMed=8590280; DOI=10.1093/dnares/2.4.167;
RA   Nagase T., Seki N., Tanaka A., Ishikawa K., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. IV.
RT   The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 2:167-174(1995).
RN   [3]
RP   SEQUENCE REVISION.
RX   MEDLINE=22158633; PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 866-1323 (ISOFORM 1).
RC   TISSUE=Brain;
RX   MEDLINE=97264341; PubMed=9110174;
RA   Yu W., Andersson B., Worley K.C., Muzny D.M., Ding Y., Liu W.,
RA   Ricafrente J.Y., Wentland M.A., Lennon G., Gibbs R.A.;
RT   "Large-scale concatenation cDNA sequencing.";
RL   Genome Res. 7:353-358(1997).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-524; SER-533; SER-1273;
RP   SER-1277 AND SER-1280, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   STRUCTURE BY NMR OF 131-237.
RX   PubMed=12377121; DOI=10.1016/S0969-2126(02)00857-2;
RA   Amezcua C.A., Harper S.M., Rutter J., Gardner K.H.;
RT   "Structure and interactions of PAS kinase N-terminal PAS domain: model
RT   for intramolecular kinase regulation.";
RL   Structure 10:1349-1361(2002).
RN   [10]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-11; ILE-250; ARG-426; ALA-512;
RP   SER-514; ARG-684; ASP-725; LYS-796; GLN-844; HIS-937; MET-1210;
RP   CYS-1266 AND SER-1301.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Activated by autophosphorylation on Thr-1161
CC       and Thr-1165 and inhibited by the first PAS domain.
CC   -!- INTERACTION:
CC       Self; NbExp=1; IntAct=EBI-1042651, EBI-1042651;
CC       P22087:FBL; NbExp=1; IntAct=EBI-1042651, EBI-358318;
CC       P20618:PSMB1; NbExp=1; IntAct=EBI-1042651, EBI-372273;
CC       O75716:STK16; NbExp=1; IntAct=EBI-1042651, EBI-749295;
CC       P61964:WDR5; NbExp=1; IntAct=EBI-1042651, EBI-540834;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96RG2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96RG2-2; Sequence=VSP_009302;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, with slightly higher
CC       expression in brain, prostate and testis. Reduced expression was
CC       found in placenta.
CC   -!- PTM: Autophosphorylated on Thr-1161 and Thr-1165.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family.
CC   -!- SIMILARITY: Contains 2 PAS (PER-ARNT-SIM) domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA09484.2; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF387103; AAK69752.1; -; mRNA.
DR   EMBL; D50925; BAA09484.2; ALT_INIT; mRNA.
DR   EMBL; CR749231; CAH18087.1; -; mRNA.
DR   EMBL; BC043495; AAH43495.1; -; mRNA.
DR   EMBL; BC063585; AAH63585.1; -; mRNA.
DR   EMBL; U79240; AAB50198.1; -; mRNA.
DR   IPI; IPI00398824; -.
DR   IPI; IPI00398825; -.
DR   PIR; T17211; T17211.
DR   RefSeq; NP_055963.2; -.
DR   UniGene; Hs.397891; -.
DR   PDB; 1LL8; NMR; -; A=131-237.
DR   PDB; 3DLS; X-ray; 2.30 A; A/B/C/D/E/F=977-1300.
DR   PDBsum; 1LL8; -.
DR   PDBsum; 3DLS; -.
DR   ProteinModelPortal; Q96RG2; -.
DR   IntAct; Q96RG2; 5.
DR   STRING; Q96RG2; -.
DR   PhosphoSite; Q96RG2; -.
DR   PRIDE; Q96RG2; -.
DR   Ensembl; ENST00000234040; ENSP00000234040; ENSG00000115687.
DR   Ensembl; ENST00000405260; ENSP00000384016; ENSG00000115687.
DR   GeneID; 23178; -.
DR   KEGG; hsa:23178; -.
DR   UCSC; uc002wao.1; human.
DR   UCSC; uc010fzl.1; human.
DR   CTD; 23178; -.
DR   GeneCards; GC02M242065; -.
DR   H-InvDB; HIX0200273; -.
DR   HGNC; HGNC:17270; PASK.
DR   HPA; HPA016450; -.
DR   HPA; HPA021079; -.
DR   MIM; 607505; gene.
DR   PharmGKB; PA32953; -.
DR   HOVERGEN; HBG047936; -.
DR   OMA; RWSSYCL; -.
DR   OrthoDB; EOG9RBT55; -.
DR   PhylomeDB; Q96RG2; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 44625; -.
DR   ArrayExpress; Q96RG2; -.
DR   Bgee; Q96RG2; -.
DR   CleanEx; HS_PASK; -.
DR   Genevestigator; Q96RG2; -.
DR   GermOnline; ENSG00000115687; Homo sapiens.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004871; F:signal transducer activity; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-dependent; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR013767; PAS_fold.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00989; PAS; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00091; PAS; 2.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   TIGRFAMs; TIGR00229; sensory_box; 1.
DR   PROSITE; PS50112; PAS; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Repeat; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1   1323       PAS domain-containing serine/threonine-
FT                                protein kinase.
FT                                /FTId=PRO_0000086480.
FT   DOMAIN      119    190       PAS 1.
FT   DOMAIN      335    402       PAS 2.
FT   DOMAIN      999   1251       Protein kinase.
FT   NP_BIND    1005   1013       ATP (By similarity).
FT   ACT_SITE   1128   1128       Proton acceptor.
FT   BINDING    1028   1028       ATP (By similarity).
FT   MOD_RES     116    116       Phosphoserine.
FT   MOD_RES     524    524       Phosphoserine.
FT   MOD_RES     533    533       Phosphoserine.
FT   MOD_RES    1161   1161       Phosphothreonine.
FT   MOD_RES    1165   1165       Phosphothreonine.
FT   MOD_RES    1273   1273       Phosphoserine.
FT   MOD_RES    1277   1277       Phosphoserine.
FT   MOD_RES    1280   1280       Phosphoserine.
FT   VAR_SEQ    1111   1111       Q -> QVRAGQSR (in isoform 2).
FT                                /FTId=VSP_009302.
FT   VARIANT      11     11       E -> K (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_040986.
FT   VARIANT     250    250       V -> I (in dbSNP:rs1470414).
FT                                /FTId=VAR_028293.
FT   VARIANT     426    426       Q -> R (in dbSNP:rs35187712).
FT                                /FTId=VAR_040987.
FT   VARIANT     512    512       T -> A (in dbSNP:rs56033464).
FT                                /FTId=VAR_040988.
FT   VARIANT     514    514       L -> S (in dbSNP:rs2240543).
FT                                /FTId=VAR_028294.
FT   VARIANT     684    684       P -> R (in dbSNP:rs56372985).
FT                                /FTId=VAR_040989.
FT   VARIANT     694    694       V -> M (in dbSNP:rs6727226).
FT                                /FTId=VAR_028295.
FT   VARIANT     725    725       G -> D (in dbSNP:rs2005771).
FT                                /FTId=VAR_028296.
FT   VARIANT     796    796       E -> K (in dbSNP:rs35129131).
FT                                /FTId=VAR_040990.
FT   VARIANT     844    844       P -> Q (in dbSNP:rs36082918).
FT                                /FTId=VAR_040991.
FT   VARIANT     937    937       R -> H (in dbSNP:rs56139954).
FT                                /FTId=VAR_040992.
FT   VARIANT    1210   1210       V -> M (in dbSNP:rs10167000).
FT                                /FTId=VAR_028297.
FT   VARIANT    1266   1266       F -> C (in dbSNP:rs1131293).
FT                                /FTId=VAR_028298.
FT   VARIANT    1301   1301       P -> S.
FT                                /FTId=VAR_040993.
FT   MUTAGEN    1028   1028       K->R: Loss of autophosphorylating
FT                                activity.
FT   MUTAGEN    1161   1161       T->A: Loss of catalytic activity.
FT   MUTAGEN    1165   1165       T->A: Loss of catalytic activity.
FT   CONFLICT    205    205       S -> T (in Ref. 2; BAA09484).
FT   CONFLICT    407    407       S -> C (in Ref. 4; CAH18087).
FT   CONFLICT    623    623       S -> R (in Ref. 2; BAA09484).
FT   CONFLICT    741    741       W -> R (in Ref. 4; CAH18087).
FT   CONFLICT    850    850       T -> M (in Ref. 2; BAA09484).
FT   CONFLICT    899    899       Y -> H (in Ref. 1; AAK69752).
FT   CONFLICT   1048   1048       K -> E (in Ref. 4; CAH18087).
FT   CONFLICT   1129   1129       I -> F (in Ref. 6; AAB50198).
FT   STRAND      133    138
FT   TURN        139    141
FT   STRAND      143    147
FT   HELIX       151    155
FT   TURN        159    161
FT   HELIX       167    170
FT   TURN        174    176
FT   HELIX       177    181
FT   STRAND      188    191
FT   STRAND      198    203
FT   STRAND      211    214
FT   STRAND      221    234
SQ   SEQUENCE   1323 AA;  142929 MW;  F8A3633CC6F6C8CD CRC64;
     MEDGGLTAFE EDQRCLSQSL PLPVSAEGPA AQTTAEPSRS FSSAHRHLSR RNGLSRLCQS
     RTALSEDRWS SYCLSSLAAQ NICTSKLHCP AAPEHTDPSE PRGSVSCCSL LRGLSSGWSS
     PLLPAPVCNP NKAIFTVDAK TTEILVANDK ACGLLGYSSQ DLIGQKLTQF FLRSDSDVVE
     ALSEEHMEAD GHAAVVFGTV VDIISRSGEK IPVSVWMKRM RQERRLCCVV VLEPVERVST
     WVAFQSDGTV TSCDSLFAHL HGYVSGEDVA GQHITDLIPS VQLPPSGQHI PKNLKIQRSV
     GRARDGTTFP LSLKLKSQPS SEEATTGEAA PVSGYRASVW VFCTISGLIT LLPDGTIHGI
     NHSFALTLFG YGKTELLGKN ITFLIPGFYS YMDLAYNSSL QLPDLASCLD VGNESGCGER
     TLDPWQGQDP AEGGQDPRIN VVLAGGHVVP RDEIRKLMES QDIFTGTQTE LIAGGQLLSC
     LSPQPAPGVD NVPEGSLPVH GEQALPKDQQ ITALGREEPV AIESPGQDLL GESRSEPVDV
     KPFASCEDSE APVPAEDGGS DAGMCGLCQK AQLERMGVSG PSGSDLWAGA AVAKPQAKGQ
     LAGGSLLMHC PCYGSEWGLW WRSQDLAPSP SGMAGLSFGT PTLDEPWLGV ENDREELQTC
     LIKEQLSQLS LAGALDVPHA ELVPTECQAV TAPVSSCDLG GRDLCGGCTG SSSACYALAT
     DLPGGLEAVE AQEVDVNSFS WNLKELFFSD QTDQTSSNCS CATSELRETP SSLAVGSDPD
     VGSLQEQGSC VLDDRELLLL TGTCVDLGQG RRFRESCVGH DPTEPLEVCL VSSEHYAASD
     RESPGHVPST LDAGPEDTCP SAEEPRLNVQ VTSTPVIVMR GAAGLQREIQ EGAYSGSCYH
     RDGLRLSIQF EVRRVELQGP TPLFCCWLVK DLLHSQRDSA ARTRLFLASL PGSTHSTAAE
     LTGPSLVEVL RARPWFEEPP KAVELEGLAA CEGEYSQKYS TMSPLGSGAF GFVWTAVDKE
     KNKEVVVKFI KKEKVLEDCW IEDPKLGKVT LEIAILSRVE HANIIKVLDI FENQGFFQLV
     MEKHGSGLDL FAFIDRHPRL DEPLASYIFR QLVSAVGYLR LKDIIHRDIK DENIVIAEDF
     TIKLIDFGSA AYLERGKLFY TFCGTIEYCA PEVLMGNPYR GPELEMWSLG VTLYTLVFEE
     NPFCELEETV EAAIHPPYLV SKELMSLVSG LLQPVPERRT TLEKLVTDPW VTQPVNLADY
     TWEEVFRVNK PESGVLSAAS LEMGNRSLSD VAQAQELCGG PVPGEAPNGQ GCLHPGDPRL
     LTS
//
